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Abstract
Introduction: An 82-year-old Caucasian woman had remained in a persistent vegetative state after a coma of
seven months duration, which occurred after a stroke with hemiplegia, nine years previously. The persistent
vegetative state could be reversed in part by weekly injections with activated immune cells. After therapy, our
patient responded to commands in addition to regaining spontaneous movements of both arms and the ability to
swallow. This is the first report on the treatment with activated immune cells of a patient in a persistent vegetative
state after a coma.
Case presentation: An 82-year-old Caucasian woman presented with a persistent vegetative state subsequent to a
coma. She retained respiratory and autonomic functions. As contact was not possible, physiotherapy was passive.
Her skin was yellowish, and our patient did not move by herself. Vomiting repeatedly resulted from tube feeding.
After a once-weekly treatment with activated immune cells sampled from our patient’s blood and activated in vitro,
several of her functions gradually returned. Our patient opened her eyes in the requested direction and turned her
head toward people entering the room. She ‘supported’ nursing efforts, as the nurse noted a loss of spastic
motions. The strength in both her arms returned, and she spontaneously moved her arm on the side experiencing
hemiplegia. After three months, our patient could stick out her tongue upon demand. Finally, the swallow reflexes
of our patient started to return. However, tube feeding was continued, and our patient died after aspiration of
vomit following a feeding.
Conclusion: The success of treatment with autologous activated immune cells in this patient may have resulted from
the production of neuroactive substances, such as neurotrophin-3 and brain-derived neurotrophic factor, by activated
immune cells. The deterioration of our patient could be reversed, as demonstrated by the restoration of motor strength
in her hemiplegic side. In addition, our patient was able to induce motor responses upon request. It seems reasonable
to conclude that activated immune cells may improve the chronic vegetative state in some patients.
Introduction
At the Institute of Immunology of the University of
Munich, we have successfully treated several patients
with psychiatric diseases with autologous activated
immune cells (ACT). The treatment concept was based
on previous observations of patients with persistent
infections with Chlamydophila and the observed ability
of immune cells to produce neuroactive substances
[1-3]. The son of the patient in our case report had wit-
nessed the tantrum of an autistic child and the subse-
quent dramatic improvements of the child after
receiving activated immune cells [2]. He asked us
whether we could help his mother. We agreed that we
could and he discussed this with other family members.
They encouraged him to proceed with treating his
mother with activated immune cells.
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An 82-year-old Caucasian woman presented to our
clinic with a persistent vegetative state after a coma. She
was admitted at the age of 73 years, one year after a
stroke, to the neurologic rehabilitation department of a
Bavarian hospital. The diagnoses at that time included
motor hemiparesis, motor aphasia, an inability to speak,
an inability to swallow and an inability to actively move
or react to contact attempts. She groaned continuously
and on neurological examination, both her pupils were
round and reacted directly and indirectly to light. It was
not possible to examine her coordination because of an
inability to stand or walk. In addition, she had no reac-
tion on sensibility tests. A sensory aphasia was assumed.
Electroencephalography indicated a left-sided fronto-
temporal theta-delta state and no epilepsy-specific signs.
Computed tomography indicated an extensive infarction
and/or occlusion of the left middle cerebral artery and a
widened left ventricle as well as a lowered density of her
left basis pontis and brain stem. The reported laboratory
values for her blood, liver and kidneys were in the nor-
mal range.
Therapeutic modalities inst i g a t e da tt h a tt i m eb yt h a t
hospital included a continuation of anticoagulation ther-
apy which had started one year prior. A urinary infection
that was discovered was treated with norfloxacin (based
on resistance tests). Any logopedic or physiotherapeutic
action was considered to be fortuitous, as only passive
physiotherapy was possible. A feeding tube was inserted
because of the patient’s inability to swallow. She was dis-
missed from that hospital after six weeks for care at home.
It was assumed that she would survive only a few months
and that she should live the last months of her life in the
home environment. The nursing was to be administered
by her relatives, all farmers, with a nurse coming every
day. Unless a special event necessitated an earlier visit, a
family doctor visited every two weeks.
Nine years after her initial stroke, the 82-year-old
woman had passed into a deep sleeplike state that had
already lasted seven months, as the woman became our
patient. Patient contact was not possible, and there were
few vocal signs, such as groaning or cries. Her limbs
had to be passively moved, as no active physiotherapy
could be induced. She did not change position in the
bed by herself, and active movements with her arms or
legs were not observed. The only remaining signs of
patient activity were vocal signs such as uttering of the
same word, ‘Maria’, or occasional groaning. She was
continuously administered anticoagulant therapy and
artificial feeding. A search for microbial infections indi-
cated serologically significant immunoglobulin G and
immunoglobulin A titers against Chlamydia trachoma-
tis, Chlamydophila pneumoniae and a suspected reacti-
vation of Epstein-Barr virus
After isolation of immune cells from her peripheral
blood, as described elsewhere [4], the immune cells
were incubated in vitro with the OKT3 anti-CD3 anti-
body (ORTHOCLONE, muromonab-CD3 human T cell
blocker, Janssen-Cilag, Neuss, Germany), which activates
T lymphocytes. The stimulated T lymphocytes activate
other immune cells, mainly monocytes and dendritic
cells, and produce neuroactive substances [5]. These in
vitro-activated mononuclear immune cells were adminis-
tered by intramuscular injection. Alternatively, the acti-
vated immune cells were used to activate other not yet
activated immune cells in vitro.T h e s e‘cascade primed’
immune cells better recognize and eliminate infected
cells and cancer cells [6]. As described previously for
the treatment of patients with schizophrenia or depres-
sion [2], approximately 40 × 10
6 to 60 × 10
6 autologous
activated immune cells were injected intramuscularly
once per week.
Several changes in the behavior of our patient could
be observed after the initiation of ACT. After the first
injections, our patient opened her eyes upon demand
and moved them in the requested directions. Further-
more, our patient’s eyes followed the person entering
the room, and she was able to turn her head (Figure 1,
month one). Other motor function improvements
occurred more slowly, but our patient was able to
change her side position in bed by herself and, after six
weeks, she could grab for the bar of the bed with the
hemiplegic-side hand (Figure 1, month two). Six months
after beginning the immune cell therapy, a logopedist
started training for the swallow reflex and soon claimed
that our patient could swallow independently. The nurse
had observed that our patient independently move her
tongue during tooth brushing. Although our patient
grabbed the hands of her grandchildren with both
hands, held them for a lengthy period and looked at the
children, this was not definite proof that she recognized
them. Unfortunately, our patient died after a night-time
tube feeding after aspirating vomit.
Discussion
Our patient was nursed at home for nine years. She had
to be turned on her side in the last seven months. In
addition, no active movement was registered, and no
patient contact was possible. She was tube fed. The first
signs of new neural activities were only observed after
the first weekly ACT injections (Figure 1, month one).
Eye-opening was not considered a useful sign of
improvement, but the autonomously turning of her
head and eyes toward people entering the room was
interpreted as a sign of initial improvement in sensory
perception. This interpretation was supported by the
repeated response to requests to move her eyes in a spe-
cific direction (Figure 1, month two). The motor
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after a few weeks, and spontaneous movement of her
arm on the hemiplegic side was observed after four
months (Figure 1, month four). At that time, our patient
could stick out her tongue upon request, a sign of both
sensory and motor improvement. The logopedist
initiated swallow reflex training and claimed after sev-
eral sessions that the reflex was working (Figure 1,
month six). However, the relatives and the nurse were
not convinced of this progress, although the swallowing
of a spoonful of tea seemed possible. In additon, the
nurse noted one time in the care diary that she saw the
patient swallowing after hearing the husband swallow-
ing. During a session of night-time tube feeding, the
patient vomited and then aspirated the vomit, which
resulted in her immediate death.
There are rare examples of recovery in all stages of
coma. In this patient, there was no clear evidence of recov-
ery from the dementia state; however, signs of gradual
improvement in her sensory perception and motor func-
tions were observed. The gradual improvement
accompanied the continuation of weekly injections with
autologous activated immune cells. Whether this recovery
would have continued with additional cell therapy cannot
be answered. Activated immune cells can pass the blood
brain barrier. If the assumption that the improvements in
this patient were based on the ACT is accepted, then it is
important to consider which mechanism might be respon-
sible for the observed improvement in the function of
nerve cells. It is possible that the supply of neuroactive
substances by immune cells such as neurotrophin-3,
brain-derived neurotrophic factor (BDNF) and others may
‘restart’ or improve synaptic activities, as they are known
to enhance the release of neurotransmitters from neurons
[7,8]. The participation of BDNF in the repair of nerve
injuries in the periphery may also be observed in the cen-
tral nervous system [9].
Conclusion
Therapy with activated immune cells may improve the
persistent vegetative statei ns o m ep a t i e n t s .T h et r u e























opens eyes first time since three months
opens eyes and turns head towards people entering the room,  
the yellowish complexion of the face turns rosy
opens eyes upon demand and in the requested direction, holds the hands of grandchildren with 
the hand of the (hemiplegic) right side, seems not to recognise them 
tries to stop dental care of the nurse with the right (hemiplegic) arm, 
starts to talk to herself for hours, embraces the nurse
strucks out the tongue upon demands
swallows tea by spoonfulls
g
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Figure 1 shows the number of injections over a time period of eight months and resulting improvements in the patient’s status. Each
“+” represents an injection. The activated autologous immune cells were administered weekly. Black arrows illustrate the respective point in time
when a certain observation was made. All improvements persisted until the patient’s death.
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Written informed consent was obtained from the
patient’s son for publication of this case report and any
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this journal
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